News
43m
Asianet Newsable on MSNUS FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The FenceFDA reviewers said in briefing documents that the benefit-risk profile of the drug for the treatment of multiple myeloma “remains unclear.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results